4D pharma plc 4D Announces Positive Data From Phase 1b Study of Thetanix in Paediatric Crohn's Diseases Patients and Publication of Studies Showing Strong Efficacy of Thetanix in Preclinical Models of IBD

LEEDS United Kingdom Sept. 24 2018 GLOBE NEWSWIRE 4D pharma plc AIM DDDD a pharmaceutical company leading the development of live biotherapeutics today announces positive topline resu...